A phase II trial to investigate the efficacy of TF-0023
Latest Information Update: 10 Jun 2016
At a glance
- Drugs TF 0023 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 10 Jun 2016 New trial record
- 20 Jun 2015 The company will start the this trial in 20-40 sites in the US from July, 2015, according to a Techfields Pharma media release.